If you are a shareholder in Momenta Pharmaceuticals Inc ... A stock with a beta greater than one is considered more sensitive to market-wide shocks compared to a stock that trades below the value of one. See our latest analysis for …
Craig A Wheeler , President of Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) reportedly Sold 4,116 shares of the …
Although I have made some good gains from Momenta Pharmaceuticals ... right where the stock is trading. The view on this company varies widely among analyst firms. Maxim Group recently issued a Sell and $6 price target on MNTA. …
A month has gone by since the last earnings report for Momenta Pharmaceuticals, Inc. MNTA. Shares have lost about 9.6% in that time frame, underperforming the market. Will the recent negative trend continue leading up to the stock's …
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here. Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA) and Mylan N.V. (Nasdaq: MYL) announced that dosing has begun in a Phase 1 study to compare the …
About a month has gone by since the last earnings report for Momenta Pharmaceuticals, Inc. MNTA. Shares have added about 5.8% in that time frame, outperforming the market. Will the recent positive trend continue leading up to the …
Investors in Momenta Pharmaceuticals, Inc. MNTA need to pay close attention to the stock based on moves in the options market lately. That is because the June 16 th, 2017 $13 Put had some of the highest implied volatility of all equity …